2-21042450-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3PP5
The NM_000384.3(APOB):c.148C>T(p.Arg50Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R50Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000384.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
APOB | NM_000384.3 | c.148C>T | p.Arg50Trp | missense_variant | 3/29 | ENST00000233242.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
APOB | ENST00000233242.5 | c.148C>T | p.Arg50Trp | missense_variant | 3/29 | 1 | NM_000384.3 | P1 | |
APOB | ENST00000399256.4 | c.148C>T | p.Arg50Trp | missense_variant | 3/17 | 1 | |||
APOB | ENST00000673739.2 | c.148C>T | p.Arg50Trp | missense_variant, NMD_transcript_variant | 3/25 | ||||
APOB | ENST00000673882.2 | c.148C>T | p.Arg50Trp | missense_variant, NMD_transcript_variant | 3/23 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251494Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135922
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727228
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 04, 2023 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 50 of the APOB protein (p.Arg50Trp). This variant is present in population databases (rs749903604, gnomAD 0.003%). This missense change has been observed in individuals with autosomal dominant familial hypercholesterolemia (PMID: 24498611; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 438309). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APOB protein function with a negative predictive value of 95%. Studies have shown that this missense change alters APOB peptide levels (PMID: 24498611). This variant disrupts the p.Arg50 amino acid residue in APOB. Other variant(s) that disrupt this residue have been observed in individuals with APOB-related conditions (PMID: 29386597), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Hypercholesterolemia, familial, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | curation;literature only | Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge | Mar 01, 2016 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 24, 2023 | The p.R50W variant (also known as c.148C>T), located in coding exon 3 of the APOB gene, results from a C to T substitution at nucleotide position 148. The arginine at codon 50 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration has been reported in individuals familial hypercholesterolemia (FH), including segregating wth disease in one family (Thomas ER et al. Mol Genet Genomic Med, 2013 Sep;1:155-61; Futema M et al. J Med Genet, 2014 Aug;51:537-44). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at